Advertisement

Anemia as an Independent Predictor of Perioperative and Long-Term Cardiovascular Outcome in Patients Scheduled for Elective Vascular Surgery

Published:February 13, 2008DOI:https://doi.org/10.1016/j.amjcard.2007.11.072
      Anemia is common in patients scheduled for vascular surgery and is a risk factor for adverse cardiac outcome. However, it is unclear whether this is an independent risk factor or an expression of underlying co-morbidities. In total, 1,211 patients (77% men, 68 ± 11 years of age) were enrolled. Anemia was defined as serum hemoglobin levels <13 g/dl for men and <12 g/dl for women and was divided into tertiles to compare mild (men 12.2 to 13.0, women 11.2 to 12.0), moderate (men 11.0 to 12.1, women 10.2 to 11.1), and severe (men 7.2 to 11.0, women 7.5 to 10.1) anemia with nonanemia. Outcome measurements were 30-day and 5-year major adverse cardiac events (MACEs; cardiac death or myocardial infarction). All risk factors were noted. Multivariable logistic and Cox regression analyses were used, adjusting for all cardiac risk factors, including heart failure and renal disease. Data are presented as hazard ratios with 95% confidence intervals. In total, 74 patients (6%) had 30-day MACEs and 199 (17%) had 5-year MACEs. Anemia was present in 399 patients (33%), 133 of whom had mild anemia, 133 had moderate anemia, and 133 had severe anemia. Presence of anemia was associated with renal dysfunction, diabetes, and heart failure. After adjustment for all clinical risk factors, 30-day hazard ratios for a MACE per anemia group were 1.8 for mild (0.8 to 4.1), 2.3 for moderate (1.1 to 5.4), and 4.7 for severe (2.6 to 10.9) anemia, and 5-year hazard ratios for MACE per anemia group were 2.4 for mild (1.5 to 4.2), 3.6 for moderate (2.4 to 5.6), and 6.1 for severe (4.1 to 9.1) anemia. In conclusion, the presence and severity of preoperative anemia in vascular patients are significant predictors of 30-day and 5-year cardiac events, regardless of underlying heart failure or renal disease.
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Nutritional anaemias: report of a WHO scientific group.
        World Health Organ Tech Rep Ser. 1968; 405: 5-37
        • Horwich T.B.
        • Fonarow G.C.
        • Hamilton M.A.
        • MacLellan W.R.
        • Borenstein J.
        Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.
        J Am Coll Cardiol. 2002; 39: 1780-1786
        • Ezekowitz J.A.
        • McAlister F.A.
        • Armstrong P.W.
        Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure.
        Circulation. 2003; 107: 223-225
        • Anker S.D.
        • Negassa A.
        • Coats A.J.
        • Afzal R.
        • Poole-Wilson P.A.
        • Cohn J.N.
        • Yusuf S.
        Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.
        Lancet. 2003; 361: 1077-1183
        • Weiss G.
        Pathogenesis and treatment of anaemia of chronic disease.
        Blood Rev. 2002; 16: 87-96
        • Hogue Jr, C.W.
        • Goodnough L.T.
        • Monk T.G.
        Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy.
        Transfusion. 1999; 39: 657-660
        • Al-Ahmad A.
        • Rand W.M.
        • Manjunath G.
        • Konstam M.A.
        • Salem D.N.
        • Levey A.S.
        • Sarnak M.J.
        Reduced renal function and anemia as risk factors for mortality in patients with left ventricular dysfunction.
        J Am Coll Cardiol. 2001; 38: 955-962
        • Androne A.S.
        • Katz S.D.
        • Lund L.
        • LaManca J.
        • Hudaihed A.
        • Hryniewicz K.
        • Mancini D.M.
        Hemodilution is common in patients with advanced heart failure.
        Circulation. 2003; 107: 226-229
        • Herrlin B.
        • Nyquist O.
        • Sylven C.
        Induction of a reduction in haemoglobin concentration by enalapril in stable, moderate heart failure: a double blind study.
        Br Heart J. 1991; 66: 199-205
        • Kalra P.R.
        • Bolger A.P.
        • Francis D.P.
        • Genth-Zotz S.
        • Sharma R.
        • Ponikowski P.P.
        • Poole-Wilson P.A.
        • Coats A.J.
        • Anker S.D.
        Effect of anemia on exercise tolerance in chronic heart failure in men.
        Am J Cardiol. 2003; 91: 888-889
        • Mancini D.M.
        • Katz S.D.
        • Lang C.C.
        • LaManca J.
        • Hudaihed A.
        • Androne A.S.
        Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.
        Circulation. 2003; 107: 294-299
        • Kosiborod M.
        • Smith G.L.
        • Radford M.J.
        • Foody J.M.
        • Krumholz H.M.
        The prognostic importance of anemia in patients with heart failure.
        Am J Med. 2003; 114: 112-119
        • Langston R.D.
        • Presley R.
        • Flanders W.D.
        • McClellan W.M.
        Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction.
        Kidney Int. 2003; 64: 1398-1405
        • Levy P.S.
        • Kim S.J.
        • Eckel P.K.
        • Chavez R.
        • Ismail E.F.
        • Gould S.A.
        • Ramez Salem M.
        • Crystal G.J.
        Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis.
        Am J Physiol. 1993; 265: H340-H349
        • Levy P.S.
        • Chavez R.P.
        • Crystal G.J.
        • Kim S.J.
        • Eckel P.K.
        • Sehgal L.R.
        • Sehgal H.L.
        • Salem M.R.
        • Gould S.A.
        Oxygen extraction ratio: a valid indicator of transfusion need in limited coronary vascular reserve?.
        J Trauma. 1992; 32: 769-774
        • Duke M.
        • Abelmann W.H.
        The hemodynamic response to chronic anemia.
        Circulation. 1969; 39: 503-515
        • Go A.S.
        • Yang J.
        • Ackerson L.M.
        • Lepper K.
        • Robbins S.
        • Massie B.M.
        • Shlipak M.G.
        Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) study.
        Circulation. 2006; 113: 2713-2723
        • Kulier A.
        • Levin J.
        • Moser R.
        • Rumpold-Seitlinger G.
        • Tudor I.C.
        • Snyder-Ramos S.A.
        • Moehnle P.
        • Mangano D.T.
        • Investigators of the Multicenter Study of Perioperative Ischemia Research Group, Ischemia Research and Education Foundation
        Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery.
        Circulation. 2007; 116: 471-479
        • Carson J.L.
        • Duff A.
        • Poses R.M.
        • Berlin J.A.
        • Spence R.K.
        • Trout R.
        • Noveck H.
        • Strom B.L.
        Effect of anaemia and cardiovascular disease on surgical mortality and morbidity.
        Lancet. 1996; 348: 1055-1060
        • Wu W.C.
        • Schifftner T.L.
        • Henderson W.G.
        • Eaton C.B.
        • Poses R.M.
        • Uttley G.
        • Sharma S.C.
        • Vezeridis M.
        • Khuri S.F.
        • Friedmann P.D.
        Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery.
        JAMA. 2007; 297: 2481-2488
        • Diehm N.
        • Benenati J.F.
        • Becker G.J.
        • Quesada R.
        • Tsoukas A.I.
        • Katzen B.T.
        • Kovacs M.
        Anemia is associated with abdominal aortic aneurysm (AAA) size and decreased long-term survival after endovascular AAA repair.
        J Vasc Surg. 2007; 46: 676-681
        • Silverberg D.S.
        • Wexler D.
        • Blum M.
        • Keren G.
        • Sheps D.
        • Leibovitch E.
        • Brosh D.
        • Laniado S.
        • Schwartz D.
        • Yachnin T.
        • et al.
        The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.
        J Am Coll Cardiol. 2000; 35: 1737-1744
        • Silverberg D.S.
        • Wexler D.
        • Sheps D.
        • Blum M.
        • Keren G.
        • Baruch R.
        • Schwartz D.
        • Yachnin T.
        • Steinbruch S.
        • Shapira I.
        • Laniado S.
        • Iaina A.
        The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.
        J Am Coll Cardiol. 2001; 37: 1775-1780
        • Corwin H.L.
        • Gettinger A.
        • Fabian T.C.
        • May A.
        • Pearl R.G.
        • Heard S.
        • An R.
        • Bowers P.J.
        • Burton P.
        • Klausner M.A.
        • Corwin M.J.
        • EPO Critical Care Trials Group
        Efficacy and safety of epoetin alfa in critically ill patients.
        N Engl J Med. 2007; 357: 965-976
        • van Veldhuisen D.J.
        • Dickstein K.
        • Cohen-Solal A.
        • Lok D.J.
        • Wasserman S.M.
        • Baker N.
        • Rosser D.
        • Cleland J.G.
        • Ponikowski P.
        Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.
        Eur Heart J. 2007; 28: 2208-2216
        • Provenzano R.
        • Bhaduri S.
        • Singh A.K.
        • PROMPT Study Group
        Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study.
        Clin Nephrol. 2005; 64: 113-123
        • Drueke T.B.
        • Locatelli F.
        • Clyne N.
        • Eckardt K.U.
        • Macdougall I.C.
        • Tsakiris D.
        • Burger H.U.
        • Scherhag A.
        • CREATE Investigators
        Normalization of hemoglobin level in patients with chronic kidney disease and anemia.
        N Engl J Med. 2006; 355: 2071-2084